Enhanced Real‐Time Monitoring of Catalytic Therapy Efficacy with Dual‐Channel MRI and Fluorescent Platform
Advanced Functional Materials · 2025-01 · 35 (2)
DOI: 10.1002/adfm.202412848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 08.10.2024. Verfasst von Huiyi Liu und 11 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Ningbo Municipality.
Abstract (Originalsprache)
Catalytic therapies, such as chemodynamic therapy and ferroptosis, harness the tumor microenvironment to enhance the specificity and penetration of treatments, thus improving targeted tumor therapy. Despite these advancements, treatment effectiveness varies due to individual differences, making precise monitoring of drug activity and dosage essential to optimize therapy. Traditional imaging strategies, which monitor metal ion release or reactive oxygen species production, frequently fail to well correlate with therapeutic outcome. Herein, this study have developed an integrated self‐monitoring catalytic therapy platform that combines palladium‐ and manganese‐based nanoparticles (PdMn NPs) with caspase‐3 activated probe (Casp probe). Dual‐channel MRI and fluorescent probe, responsive to both low pH and caspase‐3 activity, significantly enhances the accuracy of real‐time therapeutic evaluations, allowing for early reporting treatment response (in 6 h), earlier than tumor volume reduction (8 days). This approach improves the assessment of therapeutic outcomes and aligns with the shift toward individualized cancer treatment protocols.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Ningbo Municipality
- China Postdoctoral Science Foundation
Zitieren
APA
Liu, H., Guo, Y., Lv, J., Xu, J., Zhang, Q., Guan, G., Zhang, C., Lu, C., Gong, Q., Liang, C., Xu, D., & Song, G. (2025). Enhanced Real‐Time Monitoring of Catalytic Therapy Efficacy with Dual‐Channel MRI and Fluorescent Platform. Advanced Functional Materials, 35(2). https://doi.org/10.1002/adfm.202412848
Vancouver
Liu H, Guo Y, Lv J, Xu J, Zhang Q, Guan G, et al. Enhanced Real‐Time Monitoring of Catalytic Therapy Efficacy with Dual‐Channel MRI and Fluorescent Platform. Advanced Functional Materials. 2025;35(2). doi:10.1002/adfm.202412848
BibTeX
@article{Liu2025,
author = {Liu, Huiyi and Guo, Yibo and Lv, Jingxia and Xu, Juntao and Zhang, Qingpeng and Guan, Guoqiang and Zhang, Cheng and Lu, Chang and Gong, Qiufang and Liang, Chao and Xu, Dong and Song, Guosheng},
title = {Enhanced Real‐Time Monitoring of Catalytic Therapy Efficacy with Dual‐Channel MRI and Fluorescent Platform},
journal = {Advanced Functional Materials},
year = {2025},
volume = {35},
number = {2},
doi = {10.1002/adfm.202412848}
}
EUVIMED